1. Home
  2. SPRO vs FAT Comparison

SPRO vs FAT Comparison

Compare SPRO & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.32

Market Cap

136.7M

Sector

Health Care

ML Signal

HOLD

Logo FAT Brands Inc.

FAT

FAT Brands Inc.

HOLD

Current Price

$0.31

Market Cap

6.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
FAT
Founded
2013
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
136.7M
6.6M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
SPRO
FAT
Price
$2.32
$0.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$10.00
AVG Volume (30 Days)
258.7K
413.8K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,549,000.00
$574,143,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.31
52 Week High
$3.22
$6.17

Technical Indicators

Market Signals
Indicator
SPRO
FAT
Relative Strength Index (RSI) 50.86 19.14
Support Level $2.26 $0.31
Resistance Level $2.37 $0.42
Average True Range (ATR) 0.07 0.04
MACD -0.00 0.03
Stochastic Oscillator 45.45 3.64

Price Performance

Historical Comparison
SPRO
FAT

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires, and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States.

Share on Social Networks: